David A. Siegel Tela Bio, Inc. Transaction History

Two Sigma Advisers, LP

  • $42.5 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$11.35 - $13.7 $135,065 - $163,030
-11,900 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$11.95 - $13.34 $166,033 - $185,345
-13,894 Reduced 53.87%
11,900 $152,000
Q3 2021

Nov 15, 2021
SELL
$12.2 - $15.93 $112,313 - $146,651
-9,206 Reduced 26.3%
25,794 $352,000
Q2 2021

Aug 16, 2021
BUY
$11.7 - $16.11 $409,500 - $563,850
35,000 New
35,000 $564,000

Others Institutions Holding TELA

# of Institutions
61
Shares Held
20.8M
Call Options Held
200
Put Options Held
1.3K
View Full List

About TELA Bio, Inc.

TELA Quotes by TradingView
  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $90M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email